https://www.selleckchem.com/pr....oducts/pf-04691502.h
COVID-19 is speculated to increase the likelihood of relapsing-remitting multiple sclerosis (RRMS) exacerbation. To investigate the association between contraction of COVID-19 and incidence of acute MS attacks in RRMS patients six months post-infection. This retrospective cohort study compares the risk of relapse in RRMS patients with (n=56) and without COVID-19 (n=69). Incidence of relapse was recorded for six-month following contraction of COVID-19. Incidence of RRMS exacerbation in patients with COVID-19 was compared to patients
Like
Comment
Share
